The Net Margin of Xeris Biopharma Holdings Inc (XERS) is -27.00%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -27.00% |
| 2023-12-31 | -37.98% |
| 2022-12-31 | -85.93% |
| 2021-12-31 | -247.38% |
| 2020-12-31 | -446.57% |
| 2019-12-31 | -4651.85% |
| 2018-12-31 | -2404.00% |
| 2017-12-31 | -1662.50% |
| 2016-12-31 | -1200.00% |